SCHEMBL4272196

SCHEMBL4272196

NCCCCC(NC(=O)CCN)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 2/20 0.65
▸ SLC6A5 Q9Y345 1/20 0.61
▸ GNPAT O15228 1/20 0.56
▸ NOD1 Q9Y239 5/20 0.50
▸ GSR P00390 1/20 0.47
▸ SLC15A2 Q16348 1/20 0.46
▸ RNPEP Q9H4A4 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ C3AR1 Q16581 1/20 0.45
▸ NMT2 O60551 1/20 0.44
▸ NMT1 P30419 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ ITGB3 P05106 1/20 0.43
▸ ITGA2B P08514 1/20 0.43
▸ CPB2 Q96IY4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL482959 1.00 FOLH1 (0.65) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL30834826 0.94 FOLH1 (0.57) FOLH1SLC6A5GNPATNOD1SLC15A2
SCHEMBL232527 0.93 SLC6A5 (0.65) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL232587 0.93 SLC6A5 (0.65) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL3496665 0.91 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL7027662 0.91 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL3496668 0.91 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL7027659 0.91 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL16927658 0.91 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR
SCHEMBL29875352 0.91 FOLH1 (0.55) FOLH1SLC6A5GNPATNOD1SLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030083380-A1 Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging YU RUEY J (US) 2003-05-01 — — US claimed
EP-0413528-B1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use YU RUEY J (US) 1995-11-15 — — EP claimed
US-5091171-A Skin disorders IGI, INC. 1992-02-25 — — US claimed
EP-0413528-A1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use Yu, Ruey J., Dr. (US) 1991-02-20 — — EP claimed
EP-2119372-A1 Aroma compositions and preparations containing N-alpha-beta-alanyl-dipeptides Symrise GmbH & Co. KG (DE) 2009-11-18 — — EP disclosed
US-6767924-B2 COMPRISES 2-KETOETHANOIC ACID FOR COSMETIC CONDITIONS AND DERMATOLOGIC DISORDERS TRISTRATA TECHNOLOGY, INC. 2004-07-27 — — US disclosed
US-20030083380-A1 Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging YU RUEY J (US) 2003-05-01 — — US disclosed
US-20030017130-A1 Additives enhancing topical applications of therapeutic agents TRISTRATA, INC. 2003-01-23 — — US disclosed
US-6191167-B1 SKIN DISORDERS TRISTRATA TECHNOLOGY, INC. 2001-02-20 — — US disclosed
US-6060512-A Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging TRISTRATA TECHNOLOGY, INC. (US) 2000-05-09 — — US disclosed
US-5886041-A SKIN DISORDERS TRISTRATA TECHNOLOGY, INC. (US) 1999-03-23 — — US disclosed
US-5886042-A PREVENTION OF IRRITATION BY INCLUDING AN ORGANIC BUFFER, E.G AN AMINO ACID, DIPEPTIDE, CREATINE; SKIN DISORDERS; COSMETICS; PH TRISTRATA TECHNOLOGY, INC. (US) 1999-03-23 — — US disclosed
US-5643961-A TREATMENT OF SKIN WITH COSMETICS TRISTRATA TECHNOLOGY, INC. (US) 1997-07-01 — — US disclosed
US-5637615-A ANTIAGING AGENT TRISTRATA TECHNOLOGY, INC. (US) 1997-06-10 — — US disclosed
US-5580563-A Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof ROCKEFELLER UNIVERSITY, THE 1996-12-03 — — US disclosed
EP-0413528-B1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use YU RUEY J (US) 1995-11-15 — — EP disclosed
EP-0671162-A2 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use Yu, Ruey J., Dr. (US) 1995-09-13 — — EP disclosed
US-5385938-A application of mixtures containing hydroxyacetic acid(or its salts) to skin IGI, INC. 1995-01-31 — — US disclosed
WO-1993022343-A1 MULTIPLE ANTIGEN PEPTIDE SYSTEM HAVING ADJUVANT PROPERTIES AND VACCINES PREPARED THEREFROM THE ROCKFELLER UNIVERSITY (US) 1993-11-11 — — WO disclosed
US-5091171-A Skin disorders IGI, INC. 1992-02-25 — — US disclosed
Send feedback